Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial

Rheumatology

Volumn 34, Issue 4, 1995, Pages 347-351

  Gestel, A M Van ^a   Laan, R F J M ^a   Haagsma, C J ^a   Van De Putte, L B A ^a   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Efficacy; Prednisone; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOGLUCOSE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GOLD THERAPY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; ADULT; ARTHRITIS, RHEUMATOID; AUROTHIOGLUCOSE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PLACEBOS; PREDNISONE;

EID: 0028997898     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/34.4.347     Document Type: Article

References (16)

1. Harris ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10;713-21.
2. Ropes MW, Bennet GA, Caleb S, Jacox R, Jessar RA. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
3. Laan RFJM, van Riel PLCM, van de Putte LBA, Van Eming LJTO, van’t Hof MA, Lemmens JAM. Low-dose prednisone induced rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993; 119:963-8.
4. Van der Heijde DMFM, van’t Hof MA, van Riel PLCM, Theunisse LM, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LBA. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49316-20.
5. Van der Heijde DMFM, van Riel PLCM, van de Putte LBA. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scand J Rheumatol 1990;19:407-12.
6. Van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, Gribnau FWJ, van de Putte LBA. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;i:1036-8.
7. Caldwell JR, Furst DE. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 1991;21:1-11.
8. Weisman MH. Should steroids be used in the management of rheumatoid arthritis? Rheum Dis Clinics North America 1993;19:189-99.
9. Ramos-Remus C, Sibley J, Russell AS. Steroids in rheumatoid arthritis: the honeymoon revisited. J Rheumatol 1992;19:667-9.
10. Weiss MM. Corticosteroids in rheumatoid arthritis. Semin Arthritis Rheum 1989;19;9-21.
11. Masi AT. Low dose glucocorticoid therapy in rheumatoid arthritis: transitional or selected add-on therapy? J Rheumatol 1983; 10:675-8.
12. Corkill MM, Kirkham BW, Chikanza IC, Gibson T, Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trial. Br J Rheumatol 1990;29:274-9.
13. Hansen TM, Kryger P, Elling H et al. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. Br Med J 1990;301:268-71.
14. Wong CS, Champion G, Smith MD et al. Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study. Ann Rheum Dis 1990;49:370-2.
15. Danao T, Segal AM. Pulsed suppressive treatment in rheumatoid arthritis: intravenous methylprednisolone and nitrogen mustard. J Rheumatol 1990; 17:893-9.
16. Smith MD, Ahern MJ, Roberts-Thomson PJ. Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis 1990;49:265-7.